Latest Insider Transactions at Unitedhealth Group Inc (UNH)
This section provides a real-time view of insider transactions for Unitedhealth Group Inc (UNH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of UNITEDHEALTH GROUP INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of UNITEDHEALTH GROUP INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 19
2022
|
Richard T Burke Director |
SELL
Open market or private sale
|
Indirect |
2,500
-0.21%
|
$1,195,000
$478.96 P/Share
|
|
May 17
2022
|
Richard T Burke Director |
SELL
Open market or private sale
|
Indirect |
2,500
-0.2%
|
$1,232,500
$493.5 P/Share
|
|
May 16
2022
|
Richard T Burke Director |
SELL
Open market or private sale
|
Indirect |
2,500
-0.2%
|
$1,232,500
$493.25 P/Share
|
|
Apr 04
2022
|
Stephen J Hemsley Director |
SELL
Bona fide gift
|
Indirect |
131,684
-100.0%
|
-
|
|
Apr 01
2022
|
Richard T Burke Director |
BUY
Grant, award, or other acquisition
|
Direct |
100
+0.07%
|
-
|
|
Apr 01
2022
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
171
+2.07%
|
-
|
|
Apr 01
2022
|
Paul R Garcia Director |
BUY
Grant, award, or other acquisition
|
Direct |
161
+3.12%
|
-
|
|
Apr 01
2022
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
269
+0.04%
|
-
|
|
Apr 01
2022
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
100
+0.27%
|
-
|
|
Apr 01
2022
|
John H Noseworthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
171
+4.81%
|
-
|
|
Apr 01
2022
|
Gail R Wilensky |
BUY
Grant, award, or other acquisition
|
Direct |
100
+0.4%
|
-
|
|
Apr 01
2022
|
Frederick William Mcnabb Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
174
+1.53%
|
-
|
|
Apr 01
2022
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
166
+2.12%
|
-
|
|
Mar 24
2022
|
Richard T Burke Director |
SELL
Open market or private sale
|
Indirect |
3,000
-0.24%
|
$1,524,000
$508.8 P/Share
|
|
Mar 23
2022
|
Richard T Burke Director |
SELL
Open market or private sale
|
Indirect |
3,000
-0.24%
|
$1,515,000
$505.67 P/Share
|
|
Mar 22
2022
|
John F Rex President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
53
+0.04%
|
-
|
|
Mar 22
2022
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.0%
|
-
|
|
Mar 22
2022
|
Gail R Wilensky |
BUY
Grant, award, or other acquisition
|
Direct |
68
+0.28%
|
-
|
|
Mar 22
2022
|
Richard T Burke Director |
SELL
Open market or private sale
|
Indirect |
4,000
-0.32%
|
$2,044,000
$511.14 P/Share
|
|
Mar 22
2022
|
Richard T Burke Director |
BUY
Grant, award, or other acquisition
|
Direct |
77
+0.05%
|
-
|
|
Mar 22
2022
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.24%
|
-
|
|
Mar 22
2022
|
Paul R Garcia Director |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.04%
|
-
|
|
Mar 22
2022
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
97
+0.26%
|
-
|
|
Mar 22
2022
|
Frederick William Mcnabb Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.13%
|
-
|
|
Mar 22
2022
|
John H Noseworthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.31%
|
-
|
|
Mar 22
2022
|
Dirk C Mc Mahon President & COO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
52
+0.08%
|
-
|
|
Mar 22
2022
|
Thomas E Roos Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20
+0.06%
|
-
|
|
Mar 22
2022
|
Brian R Thompson CEO, UnitedHealthcare |
BUY
Grant, award, or other acquisition
|
Direct |
37
+0.15%
|
-
|
|
Mar 22
2022
|
Andrew Witty CEO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
129
+0.14%
|
-
|
|
Mar 22
2022
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.3%
|
-
|
|
Feb 25
2022
|
Stephen J Hemsley Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,293
-0.22%
|
$614,175
$475.75 P/Share
|
|
Feb 25
2022
|
Dirk C Mc Mahon President & COO, UHG |
SELL
Payment of exercise price or tax liability
|
Direct |
593
-0.91%
|
$281,675
$475.75 P/Share
|
|
Feb 25
2022
|
John F Rex President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
859
-0.66%
|
$408,025
$475.75 P/Share
|
|
Feb 25
2022
|
Thomas E Roos Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
417
-1.16%
|
$198,075
$475.75 P/Share
|
|
Feb 25
2022
|
Marianne D Short EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
485
-0.35%
|
$230,375
$475.75 P/Share
|
|
Feb 25
2022
|
Brian R Thompson CEO, UnitedHealthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
455
-1.78%
|
$216,125
$475.75 P/Share
|
|
Feb 25
2022
|
Andrew Witty CEO, UHG |
SELL
Payment of exercise price or tax liability
|
Direct |
1,113
-1.18%
|
$528,675
$475.75 P/Share
|
|
Feb 25
2022
|
Richard T Burke Director |
SELL
Open market or private sale
|
Indirect |
6,000
-0.48%
|
$2,820,000
$470.38 P/Share
|
|
Feb 23
2022
|
Richard T Burke Director |
SELL
Open market or private sale
|
Indirect |
4,000
-0.32%
|
$1,860,000
$465.3 P/Share
|
|
Feb 22
2022
|
Paul R Garcia Director |
BUY
Open market or private purchase
|
Direct |
2,146
+47.47%
|
$995,744
$464.97 P/Share
|
|
Feb 22
2022
|
Dirk C Mc Mahon President & COO, UHG |
SELL
Payment of exercise price or tax liability
|
Direct |
789
-1.19%
|
$364,518
$462.51 P/Share
|
|
Feb 22
2022
|
John F Rex President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,085
-0.83%
|
$501,270
$462.51 P/Share
|
|
Feb 22
2022
|
Thomas E Roos Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
381
-1.05%
|
$176,022
$462.51 P/Share
|
|
Feb 22
2022
|
Brian R Thompson CEO, UnitedHealthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
463
-1.77%
|
$213,906
$462.51 P/Share
|
|
Feb 22
2022
|
Andrew Witty CEO, UHG |
SELL
Payment of exercise price or tax liability
|
Direct |
1,307
-1.37%
|
$603,834
$462.51 P/Share
|
|
Feb 16
2022
|
Richard T Burke Director |
SELL
Open market or private sale
|
Indirect |
5,000
-0.4%
|
$2,380,000
$476.72 P/Share
|
|
Feb 14
2022
|
Marianne D Short EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,229
-3.63%
|
$2,478,546
$474.4 P/Share
|
|
Feb 14
2022
|
Marianne D Short EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,466
+7.37%
|
$5,434,884
$474.4 P/Share
|
|
Feb 14
2022
|
John F Rex President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
24,370
+8.27%
|
$5,775,690
$237.2 P/Share
|
|
Feb 14
2022
|
John F Rex President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,775
-6.58%
|
$4,159,350
$474.4 P/Share
|